Journal of Biological ChemistryCell BiologyPeer-reviewed journal article
Downregulation of PIK3IP1/TrIP on T cells is controlled by TCR signal strength, PKC, and metalloprotease-mediated cleavage
Benjamin MurteriD, Sean C. Robinson, Hridesh BanerjeeiD, Louis LauiD, Uzodinma N. UcheiD, Andrea L. Szymczak-WorkmaniD, Larry KaneiD
- Citations
- 1
- FWCI
- 0.15
- Field percentile
- 43th percentile
Abstract
The protein known as PI3K-interacting protein (PIK3IP1), or transmembrane inhibitor of PI3K (TrIP), is highly expressed by T cells and can modulate PI3K activity in these cells. Several studies have also revealed that TrIP is rapidly downregulated following T cell activation. However, it is unclear as to how this downregulation is controlled. Using a novel monoclonal antibody that robustly stains cell-surface TrIP, we demonstrate that TrIP is lost from the surface of activated T cells in a manner dependent on the strength of signaling through the T cell receptor (TCR) and specific downstream signaling pathways, in particular classical PKC isoforms. TrIP expression returns by 24 hours after stimulation, suggesting that it may play a role in resetting TCR signaling at later time points. We also provide evidence that ADAM family proteases are required for both constitutive and stimulation-induced downregulation of TrIP in T cells. Finally, by expressing truncated forms of TrIP in cells, we identify the region in the extracellular stalk domain of TrIP that is targeted for proteolytic cleavage.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: protein folding & dynamics
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt
U. Uche, A. L. Szymczak-Workman, … L. P. Kane·bioRxiv·Nov 6, 2017
- Pik3ip1/TrIP Regulation of PI3K Restricts CD8 T Cell Anti-Tumor Immunity
Benjamin Murter, Larry Kane·bioRxiv·Jul 10, 2025
- Regulation of TCR-induced Transcriptional Kinetics by Interleukin 2-inducible T Cell Kinase (ITK) in CD8+ T cells
Josh Hunkins, Zoe K. Bedrosian, … Leslie J. Berg·bioRxiv·Sep 22, 2025
- Activated PI3Kδ specifically perturbs mouse Treg homeostasis and function leading to immune dysregulation
A. K. Singh, F. Al Qureshah, … D. J. Rawlings·bioRxiv·Dec 21, 2023
- NF-κB dependent expression of A20 controls IKK repression of RIPK1 dependent cell death in activated T cells
S. Layzell, A. Barbarulo, B. Seddon·bioRxiv·Sep 22, 2023
- TCR-dependent and TCR-independent in-vitro T cell activation generate distinct functional, metabolic, and cytokine programs: Protein kinase C signalling augments anti-CD3+anti-CD28 responses
Nikita S. Ramteke, Dipankar Nandi·bioRxiv·Jul 20, 2026